Cialis
Product Images NDC 54868-4665

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Cialis (NDC 54868-4665). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Of 10 mg Package Label (4665)

FDA Label Image

Image Of 20 mg Package Label (4968)

FDA Label Image

Image Of 5 mg Package Label (5956)

Image Of 5 mg Package Label (5956)
This is a label for Cialis medication, with the distribution information provided by Physicians Total Care. The NDC number for the medication is 54868-5956-0, and the lot number is 546. The medication's expiration date is 01/68. The remaining text is not readable.*
FDA Label Image

Chemical Structure (Cialis Uspi F001 Structure V1)

FDA Label Image

Figure (Cialis Uspi F001 V2)

Figure (Cialis Uspi F001 V2)
This is a graph showing the plasma concentration of Tadalafil (in μg/l) in the blood over time (in hours) after administration of a single dose of 5mg or 20mg of Tadalafil. There is also data for the plasma concentration after once-daily 5mg Tadalafil following 5 consecutive days of administration.*
FDA Label Image

Figure (Cialis Uspi F002 V1)

Figure (Cialis Uspi F002 V1)
This appears to be a table with headings "Difference", "Tadalafil minus Placebo, mmHg", "Standing Systolic BP", "Standing Diastolic BP", "Supine Systolic BP", "Supine Diastolic BP", and "Time (Hours)". The values under the headings seem to represent measurements in mmHg at different time intervals. It is not clear what the data is referring to or what the context is, so a more specific description cannot be provided.*
FDA Label Image

Figure (Cialis Uspi F003 V1)

Figure (Cialis Uspi F003 V1)
The text seems to contain a mix of numerical, alphabets, special characters, and a chart. Therefore, it is not possible to generate a useful description.*
FDA Label Image

Figure (Cialis Uspi F004 V1)

FDA Label Image

Figure 5 (Cialis Uspi F005 V1)

FDA Label Image

Figure 6 (Cialis Uspi F006 V1)

Figure 6 (Cialis Uspi F006 V1)
The text describes a graph or chart showing the change from baseline in IPSS total score in response to treatment with CIALIS 5mg or placebo, over a certain duration of weeks. The graph shows a statistically significant improvement in the treatment group compared to the placebo group, as indicated by the asterisk next to the p-value.*
FDA Label Image

Figure 7 (Cialis Uspi F007 V1)

Figure 7 (Cialis Uspi F007 V1)
The text describes a graph or chart showing the change from baseline in IPSS (International Prostate Symptom Score) total score over a duration of 12 weeks for two treatments: 5mg Ciaus and Placebo. The graph shows that the change in IPSS total score for Ciaus is significantly different from placebo (marked with *p<0.01).*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.